Athersys : Offering - Form 8-K -Today at 10:18 am
Re: Athersys, Inc. Offering Dear Mr. Camardo: This letter constitutes the agreement between A.G.P./Alliance Global Partners, as exclusive...
Stay updated with breaking news from Daniel Camardo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Re: Athersys, Inc. Offering Dear Mr. Camardo: This letter constitutes the agreement between A.G.P./Alliance Global Partners, as exclusive...
16.08.2023 - Athersys, Inc. (Nasdaq: ATHX), a regenerative medicine company developing MultiStem (invimestrocel) cell therapy for critical care indications, announced financial results for the three and six months ended June 30, 2023 and provided a business ...
Athersys, Inc. , a regenerative medicine company developing MultiStem® cell therapy for critical care indications, announced financial results for the three and six months ended June 30, 2023 and... -Today at 05:02 pm- MarketScreener
Athx-20230728 UNITED STATES SECURITIES AND...
Athx-20230628 UNITED STATES SECURITIES AND...